WuXi AppTec Forms Medical Big Data JV with China Electronics Data

Life Science

China News Weekly 83 – Fosun Acquires China Rights to HCC Diagnostic with $10 Million Glycotest Investment

Financial Service, Life Science, Technology

FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a Nasdaq Traded Pharmaceutical Company Focusing on the Development of Cannabinoid-Based Treatments to Create Medical Cannabis Industry Innovator

Cannabis, Life Science

Fosun Acquires China Rights to HCC Diagnostic with $10 Million Glycotest Investment

Life Science

CANbridge Forms Rare Disease Drug Partnership with WuXi Biologics

Life Science

China Everbright Raises $155 Million for Third Life Science Fund

Life Science

LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical Collaboration to Evaluate the Combination of Anti-Angiogenesis and Immuno-Oncology Therapy for Patients with Advanced Hepatocellular Carcinoma (HCC)

Life Science

Reistone of Shanghai Approved for US Phase II Trial of UC Treatment

Life Science

Zai Lab Ok’d to Launch PARP Inhibitor in Hong Kong

Life Science

Gene Therapy, Gene Editing and Immuno-Oncology Creating Thousands of New Job Opportunities

Life Science

Genecast Acquires China Rights to Tumor Test from Cancer Genetics

Life Science

Ascletis’s Second HCV Treatment on Priority Review List in China

Life Science

iAnthus & MPX Bioceutical Merge to Expand Footprint into 10 States

Cannabis, Life Science

Acadia Healthcare shares jump 9% after report it’s in talks with private equity firms

Life Science

Singlera Genomics and Fudan University unveil results showing Pan-Cancer Early Detection in the Taizhou Longitudinal Study

Life Science